Skip to main content
Livermore
Livermore
ZHEN

Brainstorm Cell Therapeutics Inc.

BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001137883

No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Brainstorm Cell Therapeutics Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
38
−8 vs. Q2 2024
Shares held
11.0M
−859.5K (−7.3%) vs. Q2 2024
Total value
$2.52M
−$1.43M (−36.2%) vs. Q2 2024
New holders
6
4 more added
Sold out
14
9 more reduced

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 38 institutions
Q1 2021: 75 institutionsQ2 2021: 57 institutionsQ3 2021: 52 institutionsQ4 2021: 42 institutionsQ1 2022: 39 institutionsQ2 2022: 48 institutionsQ3 2022: 42 institutionsQ4 2022: 43 institutionsQ1 2023: 48 institutionsQ2 2023: 57 institutionsQ3 2023: 53 institutionsQ4 2023: 46 institutionsQ1 2024: 47 institutionsQ2 2024: 48 institutionsQ3 2024: 38 institutionsQ4 2024: 34 institutionsQ1 2025: 32 institutionsQ2 2025: 34 institutionsQ3 2025: 5 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2024: $2.52M
Q1 2021: $32.1MQ2 2021: $21.4MQ3 2021: $16.9MQ4 2021: $17.6MQ1 2022: $14.0MQ2 2022: $11.0MQ3 2022: $17.1MQ4 2022: $6.16MQ1 2023: $20.4MQ2 2023: $11.5MQ3 2023: $928.4KQ4 2023: $1.04MQ1 2024: $2.19MQ2 2024: $4.09MQ3 2024: $2.52MQ4 2024: $560.3KQ1 2025: $1.09MQ2 2025: $264.0KQ3 2025: $1.73KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding BCLI and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20255$1.73K
Q2 202534$264.0K
Q1 202532$1.09M
Q4 202434$560.3K
Q3 202438$2.52M
Q2 202448$4.09M
Q1 202447$2.19M
Q4 202346$1.04M
Q3 202353$928.4K
Q2 202357$11.5M
Q1 202348$20.4M
Q4 202243$6.16M
Q3 202242$17.1M
Q2 202248$11.0M
Q1 202239$14.0M
Q4 202142$17.6M
Q3 202152$16.9M
Q2 202157$21.4M
Q1 202175$32.1M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q2 2024.

Institutions holding BCLI in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Simplex Trading, LLC1,150$00.00%−4,354−79.1%Reduced
Bogart Wealth, LLC34$80.00%+34New
Northwestern Mutual Wealth Management Co161$370.00%00.0%Unchanged
JPMorgan Chase & Co175$400.00%−80−31.4%Reduced
Westside Investment Management, Inc.200$460.00%00.0%Unchanged
St Germain D J Co Inc500$1150.00%00.0%Unchanged
Reuter James Wealth Management, LLC1,034$2380.00%+1,034New
Clearstead Advisors, LLC1,500$3460.00%00.0%Unchanged
Bank of America Corp1,607$3700.00%+115+7.7%Added
UBS Group AG2,501$5750.00%−4,609−64.8%Reduced
Steward Partners Investment Advisory, LLC2,700$6220.00%00.0%Unchanged
Bangor Savings Bank4,000$9210.00%00.0%Unchanged
Activest Wealth Management5,010$1.15K0.00%−2,070−29.2%Reduced
Advisor Group Holdings, Inc.10,519$2.42K0.00%00.0%Unchanged
Jump Financial, LLC10,995$2.53K0.00%+10,995New
Nelson, Van Denburg & Campbell Wealth Management Group, LLC11,232$2.59K0.00%00.0%Unchanged
Bank of New York Mellon Corp11,994$2.76K0.00%00.0%Unchanged
Saxony Capital Management, LLC12,950$2.98K0.00%00.0%Unchanged
Creative Planning13,846$3.19K0.00%−7,080−33.8%Reduced
Two Sigma Securities, LLC19,796$4.56K0.00%−82,220−80.6%Reduced
Janney Montgomery Scott LLC20,500$5.00K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)23,356$5.37K0.00%−63,223−73.0%Reduced
Tru Independence Asset Management 2, LLC44,000$10.1K0.01%+44,000New
Group One Trading, L.P.46,754$10.8K0.00%00.0%Unchanged
Morgan Stanley49,463$11.4K0.00%+12,488+33.8%Added
Wells Fargo & Company52,777$12.2K0.00%+23,966+83.2%Added
XTX Topco Ltd53,088$12.2K0.00%+53,088New
Jmac Enterprises LLC65,430$15.1K0.00%00.0%Unchanged
Raymond James & Associates95,153$21.9K0.00%−16,132−14.5%Reduced
Northern Trust Corp112,358$25.9K0.00%00.0%Unchanged
State Street Corp117,260$27.0K0.00%00.0%Unchanged
Abner Herrman & Brock LLC145,500$34.0K0.00%00.0%Unchanged
Weaver Consulting Group234,356$54.0K0.02%00.0%Unchanged
Liberty Wealth Management LLC340,150$78.0K0.01%00.0%Unchanged
BlackRock, Inc.377,611$87.0K0.00%+377,611New
Geode Capital Management, LLC682,816$152.0K0.00%+198,531+41.0%Added
Vanguard Group Inc1,510,640$347.4K0.00%00.0%Unchanged
Armistice Capital, LLC6,897,653$1.59M0.04%−1,020,000−12.9%Reduced
Ikarian Capital, LLC0$00.00%−90,242−100.0%Sold out
Virtu Financial LLC0$00.00%−49,586−100.0%Sold out
Sanctuary Advisors, LLC0$00.00%−17,210−100.0%Sold out
Jane Street Group, LLC0$00.00%−19,834−100.0%Sold out
Professional Financial Advisors, LLC0$00.00%−17,279−100.0%Sold out
First Affirmative Financial Network0$00.00%−14,293−100.0%Sold out
LPL Financial LLC0$00.00%−10,052−100.0%Sold out
EverSource Wealth Advisors, LLC0$00.00%−2,128−100.0%Sold out
VisionPoint Advisory Group, LLC0$00.00%−1,944−100.0%Sold out
Cranbrook Wealth Management, LLC0$00.00%−1,000−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−364−100.0%Sold out
Mark Sheptoff Financial Planning, LLC0$00.00%−100−100.0%Sold out
Caldwell Sutter Capital, Inc.0$00.00%−157,009−100.0%Sold out
Royal Bank of Canada0$00.00%−529−100.0%Sold out
BlackRock Inc.––––Not filed
Institutional & Family Asset Management, LLC––––Not filed